Mico BioMed Co. Ltd. Cash Flow-to-Debt Ratio
Mico BioMed Co. Ltd. cash flow-to-debt ratio. Mico BioMed Co. Ltd. (214610) has a Cash Flow-to-Debt Ratio of -1.03x as of September 2025, meaning its operating cash flow of ₩-8.13 Billion could theoretically repay -1% of its total liabilities (₩7.88 Billion) in one year. Check 214610 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Mico BioMed Co. Ltd. (2016–2024)
Cash flow-to-debt ratio of Mico BioMed Co. Ltd. from 2016 to 2024. Historical debt coverage capacity for Mico BioMed Co. Ltd. across 9 annual periods. Check how aggressively does Mico BioMed Co. Ltd. reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Mico BioMed Co. Ltd. Cash Flow-to-Debt Ratio by Year (2016–2024)
Mico BioMed Co. Ltd. cash flow-to-debt ratio by year from 2016 to 2024. Year-by-year debt coverage analysis for Mico BioMed Co. Ltd.. For the full cash flow conversion analysis, see how efficiently does Mico BioMed Co. Ltd. generate cash.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.37x | ₩-10.70 Billion | ₩28.58 Billion | ▲ +17.7% |
| 2023 | -0.45x | ₩-11.36 Billion | ₩24.99 Billion | ▼ -29.2% |
| 2022 | -0.35x | ₩-14.01 Billion | ₩39.82 Billion | ▼ -49.0% |
| 2021 | -0.24x | ₩-8.60 Billion | ₩36.42 Billion | ▲ +81.0% |
| 2020 | -1.25x | ₩-18.68 Billion | ₩15.00 Billion | ▼ -186.6% |
| 2019 | -0.43x | ₩-10.43 Billion | ₩24.01 Billion | ▼ -18.0% |
| 2018 | -0.37x | ₩-6.79 Billion | ₩18.45 Billion | ▼ -65.9% |
| 2017 | -0.22x | ₩-2.89 Billion | ₩13.02 Billion | ▲ +68.6% |
| 2016 | -0.71x | ₩-3.99 Billion | ₩5.65 Billion | — |